Blog - Page 228 of 5677 - QualityStocks

ThursdayOct 02, 2025 9:00 am

DGE Hosts the 5th Investigator-Initiated Trials Summit in Philadelphia

The 5th Investigator-Initiated Trials Summit will take place in Philadelphia on November 13–14, 2025. As the premier gathering for life sciences professionals driving IIT programs, this event unites clinical leaders, researchers, and industry experts to dissect common challenges happening in the IIT space. Investigator-initiated research continues to serve as a cornerstone of clinical innovation, creating opportunities to explore new indications, expand therapeutic options, and improve patient outcomes. Hosted by Dynamic Global Events, the 5th IIT Summit features a distinguished speaking faculty offering proven strategies to streamline study activation, meet your study milestones, go over bottlenecks in clinical contracting, and much more!…

WednesdayOct 01, 2025 2:38 pm

QualityStocksNewsBreaks – Vision Marine Technologies Inc. (NASDAQ: VMAR) Sets Standard in High-Performance E-Boat Space

Vision Marine Technologies Inc. (NASDAQ: VMAR) was featured in a recent article that discusses its positioning and commitment to revolutionizing the boating experience. The company “has long demonstrated its leadership in marine electrification, with its E-Motion(TM) 180E-powered vessel holding the world record for the fastest electric boat. Set at the annual Lake of the Ozarks Shootout in Missouri, the record shows that VMAR’s craft reached an astonishing speed of 116 mph, surpassing its own previous record of 109 mph, set in 2022. This enduring achievement continues to underscore Vision Marine’s commitment to innovation and excellence in the electric marine industry.” “We’re in a…

WednesdayOct 01, 2025 1:55 pm

QualityStocksNewsBreaks – IBN Portfolio Strengthened by IgnitionX for Precision Portfolio Exposure

IBN (InvestorBrandNetwork) Dynamic Brand Portfolio, a collection of more than 65 investor focused brands built over 18 years, provides clients with expansive visibility across niche verticals and broad investor audiences. With IgnitionX layered on top, that portfolio exposure is expanded further as ad campaigns place client content programmatically within high value investor segments, amplifying reach to precisely targeted audiences across platforms including Google, Meta, TikTok, YouTube and LinkedIn. This combination allows clients to leverage the brand network for organic recognition, while using IgnitionX to insert tactical paid placement into investor feeds. The result is deeper penetration into relevant investor communities,…

WednesdayOct 01, 2025 11:15 am

GlobalTech Corp. (GLTK) Weaves a Portfolio of AI-Powered Solutions That Are Revolutionizing Industries Like Sports, E-commerce, Education and Others

GlobalTech Corp. Is a tech holding company that specializes in AI, big data, digital infrastructure, the cornerstone of the company’s growth It has a portfolio of AI-powered products and companies in numerous industries, such as education, sports, E-commerce, hiring, and others The company recently announced closing of a $1.4 million convertible note private placement, with the proceeds being used to support strategic priorities GlobalTech (OTC: GLTK) is a technology holding company that specializes in industries like AI, big data, and digital infrastructure. The company continues to evaluate technology-centric acquisitions while also expanding through strategic regional alliances. GLTK has a strong…

WednesdayOct 01, 2025 11:15 am

Oncotelic Therapeutics Inc. (OTLC) Venture Sapu Nano Receives Approval to Begin Human Clinical Trials of Sapu003, an Injectible Form of Afinitor(R) (Everolimus) for Breast Cancer Treatment

Sapu Nano received approval from Australia’s Human Research Ethics Committee (“HREC”) to start enrolling patients in clinical trials for Sapu003 Sapu003 uses Sapu Nano’s Deciparticle(TM) technology to deliver more of the Everolimus drug into the bloodstream, which could be more effective than taking the drug in pill form Sapu Nano is a part of a family of companies formed through GMP Biotechnology Limited, which itself is a joint venture between Oncotelic Therapeutics, Inc. (OTCQB: OTLC) and Dragon Overseas Capital Limited Sapu Nano, part of a group of companies formed through GMP Biotechnology Limited, which is a joint venture between Oncotelic…

WednesdayOct 01, 2025 10:05 am

QualityStocksNewsBreaks – Big Tree Cloud Holdings Limited (NASDAQ: DSY, NASDAQ: DSYWW) Prices $5 Million Registered Direct Offering

Big Tree Cloud Holdings Limited (NASDAQ: DSY, NASDAQ: DSYWW) announced it has entered into a definitive agreement with an institutional investor for a registered direct offering of 8,064,516 ordinary shares at $0.62 per share, for expected gross proceeds of approximately $5 million before fees and expenses. The offering, led by Aegis Capital Corp. as exclusive placement agent, is expected to close on or about Sept. 30, 2025, subject to customary closing conditions, with proceeds earmarked for general corporate purposes and working capital. To view the full press release, visit https://ibn.fm/i5xDW About Big Tree Cloud Founded in 2020, Big Tree Cloud is…

WednesdayOct 01, 2025 9:51 am

QualityStocksNewsBreaks – LaFleur Minerals Inc. (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) Begins Trading on Tradegate Exchange in Berlin

This article has been disseminated on behalf of LaFleur Minerals and may include paid advertising. LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced that its shares are now listed on the Tradegate Exchange in Berlin, Germany, one of Europe’s most active investor-focused platforms, marking a key step in expanding its global shareholder base and access to European capital markets as the Company advances from explorer to fully integrated gold producer at its Beacon Gold Mill in the Abitibi Gold Belt; the listing, which does not involve issuance of new shares or dilution, complements its primary CSE listing and provides broader visibility,…

WednesdayOct 01, 2025 9:45 am

SuperCom Ltd. (NASDAQ: SPCB) Expands European Presence with New $7 Million German Contract, Covering Multiple Programs

The electronic monitoring (“EM”) company won Germany’s national EM contract, valued at up to $7 million over four years. SuperCom displaced a provider that had supplied the country’s EM technology for more than 20 years. Germany becomes the ninth nation to adopt SuperCom’s domestic violence solution. Contract covers multiple programs, including GPS tracking, domestic violence monitoring, home detention, and alcohol monitoring. SuperCom (NASDAQ: SPCB), a global provider of secured e-Government, IoT, and cybersecurity solutions, has been awarded a national electronic monitoring (“EM”) contract in Germany, marking a strategic expansion into Europe’s largest economy. The program budget is estimated at $7…

WednesdayOct 01, 2025 9:00 am

Lantern Pharma Inc.’s (NASDAQ: LTRN) AI-powered PredictBBB.ai Platform Helps Hoth Therapeutics Streamline Candidate Selection in Drug Development

Hoth Therapeutics (NASDAQ: HOTH) is using Lantern Pharma’s (NASDAQ: LTRN) PredictBBB.ai(TM) platform to accelerate development timelines, reduce risk, and improve candidate selection. This technology helps determine whether or not a candidate is able to cross the blood-brain barrier or not, which is a major holdup for many drug development companies. Leadership at both Lantern Pharma and Hoth Therapeutics are enthusiastic about the collaboration and how it can help deliver life-changing therapies for patients. Hoth Therapeutics (NASDAQ: HOTH), a biopharmaceutical company, recently announced that the company is using an AI-powered platform developed by Lantern Pharma (NASDAQ: LTRN), a clinical-stage biotech company…

WednesdayOct 01, 2025 9:00 am

QualityStocksNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Closes $7.5 Million Public Offering to Extend Cash Runway Through 2026

Soligenix (NASDAQ: SNGX), a late-stage biopharmaceutical company focused on treatments for rare diseases, announced the closing of its $7.5 million public offering of 5,555,560 shares of common stock and accompanying warrants at $1.35 per share, with proceeds intended to fund R&D, commercialization, working capital, and general corporate purposes; the financing, which included participation from existing and institutional healthcare investors, also amends prior warrants to a $1.35 exercise price and extends the company’s cash runway through the end of 2026. To view the full press release, visit https://ibn.fm/SXoge About Soligenix Soligenix is a late-stage biopharmaceutical company focused on developing and commercializing…

Site Search

Company Search